Jalava Tarja, Sarna Seppo, Pylkkänen Liisa, Mawer Barbara, Kanis John A, Selby Peter, Davies Michael, Adams Judith, Francis Roger M, Robinson John, McCloskey Eugene
Leiras, Helsinki, Finland.
J Bone Miner Res. 2003 Jul;18(7):1254-60. doi: 10.1359/jbmr.2003.18.7.1254.
Determinants of mortality were studied in a prospective study of 677 women and men with primary or secondary osteoporosis. Prevalent vertebral fractures were associated with increased mortality, but other known predictors of mortality explain a significant proportion of the excess risk.
In population studies, prevalent vertebral fractures are associated with increased mortality. It is unknown whether this excess mortality is related to low bone mineral density or its determinants or whether there is an additional component associated with fracture itself.
We studied 677 women and men with osteoporosis, 28-88 years old, of whom 352 had morphometrically determined vertebral fracture, to examine the risk and causes of mortality in patients with osteoporosis (defined densitometrically as a spine bone mineral density T-score < -2.5 and -3.0 for women and men, respectively, and/or one or more prevalent vertebral fractures without a history of significant trauma). The participants had enrolled in a double-blind placebo-controlled study in osteoporosis and were comprised of 483 women with postmenopausal osteoporosis, 110 women with secondary osteoporosis, and 84 men with osteoporosis of any cause. Demographics, medical history, and other measures of skeletal and nonskeletal health status were assessed at entry.
During a median follow-up of 3.2 years, 37 (5.5%) participants died, with 31 of these deaths occurring in those with prevalent vertebral fractures. Compared with participants who did not have a prevalent vertebral fracture, those with one or more fractures had a 4.4-fold higher (95% CI, 1.85, 10.6) mortality rate. After adjustment for predictors for poor health--including number of medications, number of diseases, use of oral corticosteroids, alcohol intake, serum albumin and erythrocyte sedimentation rate (ESR), renal function, height, weight, gender, and age--the point estimate of risk remained elevated but was no longer statistically significant (hazard ratio, 2.4; 95% CI, 0.93, 6.23).
Prevalent vertebral fractures in osteoporotic patients are associated with increased mortality. Other known predictors of mortality can explain a significant proportion of the excess risk.
在一项对677例原发性或继发性骨质疏松症男女患者的前瞻性研究中,对死亡率的决定因素进行了研究。现患椎体骨折与死亡率增加相关,但其他已知的死亡率预测因素可解释相当一部分额外风险。
在人群研究中,现患椎体骨折与死亡率增加相关。目前尚不清楚这种额外的死亡率是与低骨密度或其决定因素有关,还是存在与骨折本身相关的其他因素。
我们研究了677例年龄在28至88岁之间的骨质疏松症男女患者,其中352例经形态学测定存在椎体骨折,以检查骨质疏松症患者(根据骨密度测定定义为女性和男性的脊柱骨矿物质密度T值分别<-2.5和-3.0,和/或有一处或多处现患椎体骨折且无重大创伤史)的死亡风险和原因。参与者参加了一项骨质疏松症的双盲安慰剂对照研究,包括483例绝经后骨质疏松症女性、110例继发性骨质疏松症女性和84例任何原因导致的骨质疏松症男性。在入组时评估人口统计学、病史以及骨骼和非骨骼健康状况的其他指标。
在中位随访3.2年期间,37例(5.5%)参与者死亡,其中31例死亡发生在有现患椎体骨折的患者中。与没有现患椎体骨折的参与者相比,有一处或多处骨折的参与者死亡率高4.4倍(95%可信区间,1.85, 10.6)。在对健康状况不佳的预测因素进行调整后——包括用药数量、疾病数量、口服糖皮质激素的使用、酒精摄入量、血清白蛋白和红细胞沉降率(ESR)、肾功能、身高、体重、性别和年龄——风险的点估计值仍然升高,但不再具有统计学意义(风险比,2.4;95%可信区间,0.93, 6.23)。
骨质疏松症患者的现患椎体骨折与死亡率增加相关。其他已知的死亡率预测因素可解释相当一部分额外风险。